Issue link: https://www.e-digitaleditions.com/i/1515319
Inhalation February 2024 31 Inhalation and nasal DPI formulations, devices and manufacturing Hovione provides specialist expertise and leadership in particle engineering to ensure that your inhala- tion and nasal therapies are engineered for success from start to finish. Fully integrated in one site, Hovione complements this by offering simple, pat- ented and globally competitive dry powder inhal- ers—disposable, capsule, blister, large dose and high performance DPIs—which are available for fully integrated turn-key development with formulation and for licensing. Hovione—Delivering solutions, every breath of the way. Hovione Portugal: +351 21 982 9000 www.hovione.com DPI formulation development and manufacturing For 25 years, Lonza has provided integrated dry pow- der inhaler (DPI) development services to advance small molecules. Our premier particle engineering platform consists of integrated product development, including optimized particle engineering, precision micro-dosing, rapid screening, clinically relevant test- ing and GMP production. Our global facilities are equipped with world-class equipment and expertise to provide end-to-end services for respiratory drugs. Contact us for more information. Lonza Small Molecules US: +1 813 286-0404 www.lonza.com www.inhalationmag.com Designed to provide educational content, the Inhalation 1-2-3 e-newsletter includes a supplier's perspective on industry issues, highlights technical articles from the magazine and previews industry conferences. Please watch for it in your inbox every other month. Sign up now by emailing your name, company name and email address to subscriptions@inhalationmag.com.